The world will now obtain the primary single-shot vaccine within the battle in opposition to the coronavirus pandemic because the FDA has awarded the Emergency Use Authorization (EUA) to COVID-19 vaccine that has been developed by the Janssen Pharmaceutical Corporations of Johnson & Johnson JNJ.
www.nasdaq.com
J&J ETFs to Shine Vibrant as FDA Grants EUA for Coronavirus Vaccine
